Z-0924-2021 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0924-2021 was initiated by Becton Dickinson & Company on Dec 9, 2020 and is designated Class II. Reason for recall: BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications The recall status is terminated (terminated Aug 10, 2022). Affected quantity: 105880 units US.

Recall details

Product Type
Devices
Report Date
Feb 3, 2021
Initiation Date
Dec 9, 2020
Termination Date
Aug 10, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
105880 units US

Product description

BD Regional Block Needles 22G x 1.50in (50 units/cs.). Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 408348

Reason for recall

BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications

Distribution pattern

Alabama, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri, Mississippi, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia. Foreign: Australia, Canada, Belgium and Singapore

Code information

All lots within expiration date UDI: (01)50382904083484

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0924-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0924-2021. Report a data issue: hello@regdatalab.com.